C O M M U N I C A T I O N S
investigate this possibility, we replaced the GluR3 C-terminal
domain with the terminus from GluR1 and coexpressed the resulting
GluR3 subunit chimera (GluR3CT1) with GluR2 in oocytes. In these
experiments, we found that, unlike wild-type GluR2/3 receptors,
GluR2/3CT1 receptors are partially inhibited by PhTx-74, consistent
with the idea that the C-terminal domains impact AMPAR
biophysics, including the binding to polyamine toxins within the
channel pore (Figure 1).
In summary, we have identified and developed a highly efficient
synthesis of the first subtype-selective inhibitor of natiVe AMPARs.
Notably, since PhTx-74 is a use-dependent inhibitor, it provides a
means of selectively blocking synaptic GluR1/2 receptors and thus
directly monitoring subtype-specific changes in the composition
of synaptic AMPA receptors proposed to underlie synaptic plastic-
ity, including hippocampal LTP.
Figure 1. PhTx-74 is a subtype-selective inhibitor of AMPARs. (A) Effect
of PhTx-74 on homomeric AMPARs (GluR1, GluR2, and GluR3). (A1)
Bar graph showing PhTx-74 inhibits GluR1 and GluR3 receptors, but not
GluR2 receptors. Percent inhibition (mean ( SEM) was calculated for each
cell (n g 5) by measuring the steady-state glutamate-evoked (100 µM)
current before and after co-applying PhTx-74 (100, 500 µM). (A2)
Representative trace showing the inhibitory effect of PhTx-74 (100 µM)
on steady-state glutamate-evoked (100 µM) currents from GluR1 receptors.
(A3) Representative trace from the same cell in (A2) showing the effect of
co-applying glutamate (100 µM) and PhTx-74 (100 µM) on GluR1 receptors.
The peak current is comparable to the steady-state current observed in (A1),
consistent with use-dependent, open-channel block. (A4) Representative
inwardly rectifying current-voltage curve measured from the same cell as
in (A2) and (A3). (B) Effect of PhTx-74 on heteromeric AMPARs (GluR1/
2, GluR2/3, GluR2/3CT1). (B1) Bar graph showing that PhTx-74 inhibits
GluR1/2, but not GluR2/3 receptors. Partial inhibition is observed at GluR2/
Acknowledgment. We thank Ning Bao and Ming An for
technical assistance. This work was supported by grants from the
Sandler Foundation and McKnight Foundation.
Supporting Information Available: Synthetic and electrophysi-
ological methods. This material is available free of charge via the
References
(1) (a) Hollmann, M.; Heinemann, S. Annu. ReV. Neurosci. 1994, 17, 31-
108. (b) Dingledine, R.; Borges, K.; Bowie, D.; Traynelis, S. F. Pharmacol.
ReV. 1999, 51, 7-61. (c) Palmer, C. L.; Cotton, L.; Henley, J. M.
Pharmacol. ReV. 2005, 57, 253-277.
(2) (a) Malinow, R.; Malenka, R. C. Annu. ReV. Neurosci. 2002, 25, 103-
126. (b) Bredt, D. S.; Nicoll, R. A. Neuron 2003, 40, 361-379. (c)
Collingridge, G. L.; Isaac, J. R.; Wang, Y. T. Nat. ReV. Neurosci. 2004,
5, 952-961. (d) Malenka, R. C.; Bear, M. F. Neuron 2004, 44, 5-21.
(3) See ref 1c and references cited therein.
(4) (a) Shi, S. H.; Hayashi, Y.; Petralia, R. S.; Zaman, S. H.; Wenthold, R.
J.; Svoboda, K.; Malinow, R. Science 1999, 284, 1811-1816. (b) Hayashi,
Y.; Shi, S. H.; Esteban, J. A.; Piccini, A.; Poncer, J. C.; Malinow, R.
Science 2000, 287, 2262-2267. (c) Shi, S.; Hayashi, Y.; Esteban, J. A.;
Malinow, R. Cell 2001, 105, 331-343.
(5) (a) Jensen, V.; Katharina, M. M. K.; Borchardt, T.; Adelmann, G.; Rozov,
A.; Burnashev, N.; Brix, C.; Frotscher, M.; Andersen, P.; Hvalby, O.;
Sakmann, B.; Seeburg, P. H.; Sprengel, R. J. Physiol. 2003, 553.3, 843-
856. (b) Jia, Z. P.; Agopyan, N.; Miu, P.; Xiong, Z. G.; Henderson, J.;
Gerlai, R.; Taverna, F. A.; Velumian, A.; MacDonald, J.; Carlen, P.;
Abramow-Newerly, W.; Roder, J. Neuron 1996, 17, 945-956. (c) Meng,
Y. H.; Zhang, Y.; Jia, Z. P. Neuron 2003, 39, 163-176.
(6) Kromann, H.; Krikstolaityte, S.; Andersen, A. J.; Andersen, K.; Krogs-
gaard-Larsen, P.; Jaroszewski, J. W.; Egebjerg, J.; Stromgaard, K. J. Med.
Chem. 2002, 45, 5745-5754.
(7) (a) Mellor, I. R.; Usherwood, P. N. R. Toxicon 2004, 43, 493-508. (b)
Stromgaard, K.; Mellor, I. Med. Res. ReV. 2004, 24, 589-620.
(8) See: Andersen, T. F.; Tikhonov, D. B.; Bolcho, U.; Bolshakov, K.; Nelson,
J. K.; Pluteanu, F.; Mellor, I. R.; Egebjerg, J.; Stromgaard, K. J. Med.
Chem. 2006, 49, 5414-5423 and references cited therein.
(9) Mansour, M.; Nagarajan, N.; Nehring, R. B.; Clements, J. D.; Rosenmund,
C. Neuron 2001, 32, 841-853.
3CT1 receptors comprised of GluR2 and chimeric GluR3 subunits in which
the GluR3 C-terminal domain has been replaced by the GluR1 C-terminus.
Percent inhibition was calculated for each cell (n g 10, across two different
batches of oocytes) as in (A1). (B2) Representative trace showing the
inhibitory effect of PhTx-74 (100 µM) on steady-state glutamate-evoked
(100 µM) currents from GluR1/2 receptors. See Figure S2 for a representa-
tive trace showing the block is use-dependent. (B3) Representative trace
from the same cell in (B2), showing the absence of an effect of NASPM
(100 µM) on glutamate-evoked currents from GluR1/2 receptors. (B4)
Representative linear current-voltage curve measured from the same cell
as in (B2) and (B3).
momers (IC50 ) 0.3 µM), had an insignificant effect on AMPA
receptor-mediated currents from these oocytes (Figure 1).
The apparent subtype-selective block of GluR1/2 but not GluR2/3
receptors by PhTx-74 is quite remarkable. Sequences lining the
pore region of AMPARs are generally thought to be the key
determinant of polyamine toxin binding (e.g., the mRNA-edited
Q/R site residue).1b However, the membrane spanning sequences
of GluR1 and GluR3 (i.e., GluR1/2 and GluR2/3 receptors),
including those lining the channel pore, are identical (Figure S1).
In contrast, the GluR1 and GluR3 C-terminal domains, which have
been shown to influence the channel conductance (i.e., rate of ion
permeation),1c are quite dissimilar and could give rise to quaternary
structural differences between the GluR1/2 and GluR2/3 open-
channel pores, thus resulting in distinct affinities for PhTx-74. To
(10) (a) Washburn, M. S.; Numberger, M.; Zhang, S.; Dingledine, R. J.
Neurosci. 1997, 17, 9393-9406. (b) Ayalon, G.; Stern-Bach, Y. Neuron
2001, 13, 103-113. (c) Greger, I. H.; Khatri, L.; Kong, X. P.; Ziff, E. B.
Neuron 2003, 40, 763-774. (d) Brorson, J. R.; Li, D. D.; Suzuki, T. J.
Neurosci. 2004, 24, 3461-3470. (e) Gouaux, E. J. Physiol. 2004, 554
(Pt 2), 249-253. (f) Madden, D. R. Nat. ReV. Neurosci. 2002, 3, 91-
101. (g) Mayer, M. L. Curr. Opin. Neurobiol. 2005, 15, 282-288.
JA0705801
9
J. AM. CHEM. SOC. VOL. 129, NO. 16, 2007 4903